Methods for the treatment of vascular disorders
AssigneeSchering Corporation
InventorWilliam Kreutner
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treatment of mental and vascular disorders. In one embodiment, the present invention contemplates the administration of an anti-allergic medication to reduce a patient's symptoms of mental or vascular disorder. The patient may or may not suffer from allergic responses. Likewise, the methods of the present invention may be used to reduce or prevent the symptoms of a mental or vascular disorder. In a preferred embodiment, the anti-allergic medication is a non-sedating or low-sedating antihistamine such as loratadine or desloratadine.
Claims15
A method for treating a patient suffering from a vascular disorder, wherein said vascular disorder is associated with the inhibition of 5-HT7 receptors, and wherein said vascular disorder is selected from the group consisting of migraines, stroke and orthostatic hypotension, comprising administering a medication comprising an effective amount of an anti-allergic medication, comprising loratadine or a metabolite of loratadine, to said patient to diminish the symptoms of said vascular disorder.
A method for treating a patient known to have suffered from a vascular disorder, wherein said vascular disorder is associated with the inhibition of 5-HT7 receptors, and wherein said vascular disorder is selected from the group consisting of migraines, stroke and orthostatic hypotension, comprising administering a medication comprising an effective amount of an anti-allergic medication, comprising loratadine or a metabolite of loratadine, to said patient to diminish the symptoms of said vascular disorder.
A method for treating a patient susceptible to a vascular disorder, wherein said vascular disorder is associated with the inhibition of 5-HT7 receptors, and wherein said vascular disorder is selected from the group consisting of migraines, stroke and orthostatic hypotension, comprising administering a medication comprising an effective amount of an anti-allergic medication, comprising loratadine or a metabolite of loratadine, to said patient to diminish the symptoms of said vascular disorder.
Dependencies are inferred from the claim text.